Europe In Vitro Fertilization (IVF) Market 2022: Report Provides an In-Depth Analysis Across Eight Major Countries in the European Region

Europe In Vitro Fertilization (IVF) Market Report, published by Allied Market Research, forecasts that the European market was valued at $3,054 million in 2015 and is expected to reach $4,447 million by 2022, growing at a CAGR of 5.4% from 2016 to 2022.

The IVF market in Europe is characterized by factors such as lower fertility rates, delayed marriages, and late parenthood decisions. Subsidization of IVF treatments in Germany owing to the lowest birthrate of ~1.46 children/women is a major driving factor for the growth of this market.

In addition, the National Health Plan (NHP) covers about 50% of the total treatment cost and pays for three IVF cycles, which is expected to boost the IVF market, especially in Germany. However, lack of reimbursements and high cost of the procedure limit the growth of the European IVF market.

Download Sample @ https://www.alliedmarketresearch.com/request-sample/1823?utm_source=openpr_ss

The IVF market in Europe is anticipated to witness a continued stable growth, mainly in France, Germany, and UK. This is due to supportive regulations such as Human Fertilization and Embryo authority (HFEA) of UK, which closely regulate the functioning of IVF treatments and research in UK.

France accounted for the largest number of IVF cycles per year in 2015, whereas UK is expected to grow at the highest CAGR, in terms of volume and value. Spain is expected to be the largest contributor to overall regions revenue, growing at a CAGR of 6.1%, owing to increase in fertility tourism and high success rates for treatments provided.

Key Market Players:
• Thermo Fisher Scientific Inc.
• DRK Kliniken Berlin
• Sun Pharmaceutical Industries Ltd.
• Cadila Healthcare Ltd.
• LG Life Sciences
• EMD Serono Inc.

Europe IVF Market Key Findings:

• Fertility clinics segment is projected to grow at the highest CAGR during the forecast period.
• UK is expected possess the highest growth rate in the European IVF market, growing at a CAGR of 7.7%, in terms of revenue.
• In 2015, EU5 (Germany, France, UK, Spain, and Italy) collectively accounted for approximately three-fifths share of the market volume.
• Fresh cycle (non-donor) segment is expected be the highest revenue-generating segment, followed by thawed IVF cycle (non-donor) segment.
• Thawed IVF cycle (non-donor) segment is projected to grow at the highest CAGR of 7.2%, in terms of volume in Denmark.

Flat 20% Discount on All License Type...
https://www.alliedmarketresearch.com/checkout/910674?utm_source=openpr_ss
* Offer Valid Till 20th April 2019

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.